Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01460
|
|||||
Drug Name |
Phenethyl isothiocyanate
|
|||||
Synonyms |
Phenethyl-isothiocyanate
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Cancer [ICD11: 2A00-2F9Z] | Phase 3 | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C9H9NS
|
|||||
Canonical SMILES |
C1=CC=C(C=C1)CCN=C=S
|
|||||
InChI |
InChI=1S/C9H9NS/c11-8-10-7-6-9-4-2-1-3-5-9/h1-5H,6-7H2
|
|||||
InChIKey |
IZJDOKYDEWTZSO-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 2257-09-2
|
|||||
Pharmaceutical Properties | Molecular Weight | 163.24 | Topological Polar Surface Area | 44.4 | ||
Heavy Atom Count | 11 | Rotatable Bond Count | 3 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | |||
XLogP |
3.5
|
|||||
PubChem CID | ||||||
ChEBI ID |
CHEBI:351346
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
MRP1 | Transporter Info | Multidrug resistance-associated protein 1 | Substrate | [3] | ||
MRP2 | Transporter Info | Multidrug resistance-associated protein 2 | Substrate | [4] | ||
References | ||||||
1 | ClinicalTrials.gov (NCT02468882) Does Watercress Intake Have an Impact on Cancer Patients Outcomes: a Longitudinal Trial | |||||
2 | A prediction model of substrates and non-substrates of breast cancer resistance protein (BCRP) developed by GA-CG-SVM method. Comput Biol Med. 2011 Nov;41(11):1006-13. | |||||
3 | Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007. | |||||
4 | Transport of dietary phenethyl isothiocyanate is mediated by multidrug resistance protein 2 but not P-glycoprotein. Biochem Pharmacol. 2005 Aug 15;70(4):640-7. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.